Overview
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
Status:
Terminated
Terminated
Trial end date:
2011-10-01
2011-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
- To evaluate the effect of increasing the growth hormone dose on the statural response - To assess the value of early treatment during the course of arthritic disease by comparing the height acquired in the medium term by children in the two groups: treated from the start, or 1 year to 15 months after the diagnosis of CJA, or treated for 4 years after the diagnosisPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- This study will be proposed to all patients previously included in study CTN
97-8129-016
Exclusion Criteria:
- Discontinuation of corticosteroid therapy for more than a year during study CTN
97-8129-016
- Patients withdrawing from the study prematurely